K180936

Substantially Equivalent

ETEST Telavancin (TLA) (0.002-32 ug/mL)

Applicant: Biomerieux S.A.
Product code: JWY
Advisory panel: Microbiology
Date received: 2018-04-10
Decision date: 2018-07-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Marcy-L'Etoile, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.